Direct oral anticoagulants compared to aspirin for embolic stroke of undetermined source: A comprehensive meta-analysis

There is insufficient evidence to recommend the use of DOACs over aspirin following ESUS for the prevention of stroke recurrence. Nevertheless, the fears of increased bleed risks were also not seen. Further efforts should be directed towards identifying potential embolic sources and the population that benefit from OAC.